Skip to content

Improving physical activity and metabolic health in an ageing population

Improving physical activity and metabolic health in an ageing population - Physical activity in healthy ageing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34041
Enrollment
316
Registered
2011-08-05
Start date
2011-11-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

veroudering Healthy Ageing

Interventions

Intervention Group: Philips Directlife Intervention Program, consisting of baseline 1 week assessment period of baseline physical activity, after which 12 weeks of program aimed at increasing daily

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age between 60-70 years Low level of physical activity at baseline (as assessed by physical activity questionnaire) motivation to engage in a more active life style access to PC and knowledge how to use it

Exclusion criteria

Exclusion criteria: Known diabetes mellitus type I or II - Severe physical condition that inhibits increase in physical activity - Use of glucose lowering medication

Design outcomes

Primary

MeasureTime frame
Primary end points • Level of daily activity, as measured using the DirectLife activity monitors, expressed as activity counts per day (cnts/d). • We will use continuous glucose monitoring to assess at least the following parameters of 24-hour glucose rhythms: i) mean glucose level during , ii) standard deviation of all 24 hour glucose measurements, iii) highest peak after a meal (including one standardized oral glucose loading), iv) difference between highest and lowest level, v) nadir glucose.

Secondary

MeasureTime frame
Secondary end points - Other metabolic and anthropometric parameters, : weight, waist hip ratio, body fat percentage (BIA) and blood pressure will be measured at baseline and at the final visit, and blood sampling for total cholesterol, HDL-cholesterol, triglycerides, fasting glucose, fasting insulin and HbA1c - Well being and perceived health will be assessed by Quality of Life (QoL) SF-36 questionnaire prior to the trial and after the trial - sleep quality will be assessed by the Pittsburg Sleep Quality Index before and after the intervention.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)